Novel directions for diabetes mellitus drug discovery
Author:
Affiliation:
1. 1Laboratory of Cellular and Molecular Signaling, Newark, NJ 07101, USA
2. 2Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
3. 3New Jersey Health Sciences University, Newark, NJ 07101, USA
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1517/17460441.2013.736485
Reference126 articles.
1. Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus
2. Epidemiologic Merit of Obese-Years, the Combination of Degree and Duration of Obesity
3. Diabetes Mellitus: Channeling Care through Cellular Discovery
4. Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complications
5. Oxidative stress: Biomarkers and novel therapeutic pathways
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK;Cells;2023-11-09
2. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk;Frontiers in Immunology;2023-11-08
3. Cognitive Impairment in Multiple Sclerosis;Bioengineering;2023-07-23
4. INNOVATIVE THERAPEUTIC STRATEGIES FOR CARDIOVASCULAR DISEASE;EXCLI J;2023
5. Structure-related relationship: Plant-derived antidiabetic compounds;Studies in Natural Products Chemistry;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3